New Anti-HIV Drug Approved

FDA approved the sale of a new anti-HIV drug called etravirine, a non-nucleoside reverse transcriptase inhibitor. Etravirine, sold as Intelence, helps block an enzyme that the human immunodeficiency virus needs to multiply.